Literature DB >> 12388854

Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.

Jon Richmond1.   

Abstract

Many are critical of how regulatory testing practices have evolved and become established--critical both of the scientific rational and the animal welfare costs. The test of whether we are more enlightened than our predecessors will be whether, armed with more powerful scientific insights and a better understanding of animal welfare, we can ensure that the best animal welfare and the best science drive and shape future developments in regulatory testing. Conducting the most humane animal-based regulatory testing requires establishing and maintaining a constructive dialogue between stakeholders and acknowledging the common ground that unites. Inclusive processes with stakeholders prepared to offer public, rational justifications for their policies and processes are essential if best practice is to be identified and implemented. There is general agreement that the best animal welfare results in the best science; that regulatory requirements based on an understanding of mechanisms and early relevant biomarkers result in elegant and valid science. Thus, "alternative" methods enabling replacement, reduction, or refinement (the 3Rs) are in reality often more scientifically "advanced" and scientifically valid methods. These principles provided the incentive and framework for recent initiatives in the United Kingdom to enhance the quality of the data prepared for regulatory submission while better protecting the welfare of the animals used. Some remaining 3R opportunities are explored in this paper, and some of the commonly encountered myths about regulatory testing and perceived barriers to change are challenged. Current "threats" may indeed offer opportunities for ensuring that sound science and the best animal welfare underpin developments in regulatory testing.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2002        PMID: 12388854     DOI: 10.1093/ilar.43.suppl_1.s63

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  12 in total

1.  Behavioral screening of the LOPAC1280 library in zebrafish embryos.

Authors:  Sara M Vliet; Trina C Ho; David C Volz
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-13       Impact factor: 4.219

2.  Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's.

Authors:  T Arora; A K Mehta; V Joshi; K D Mehta; N Rathor; P K Mediratta; K K Sharma
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

3.  Reducing the stress of drug administration: implications for the 3Rs.

Authors:  Sarah A Stuart; Emma S J Robinson
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

Review 4.  Animal use in pharmacology education and research: the changing scenario.

Authors:  Dinesh K Badyal; Chetna Desai
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

Review 5.  Ethical guidelines, animal profile, various animal models used in periodontal research with alternatives and future perspectives.

Authors:  Mohan Kumar Pasupuleti; Subramanya Shetty Molahally; Supraja Salwaji
Journal:  J Indian Soc Periodontol       Date:  2016 Jul-Aug

Review 6.  Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a Glance.

Authors:  Aleksandra Zielińska; Beatriz Costa; Maria V Ferreira; Diogo Miguéis; Jéssica M S Louros; Alessandra Durazzo; Massimo Lucarini; Piotr Eder; Marco V Chaud; Margreet Morsink; Niels Willemen; Patrícia Severino; Antonello Santini; Eliana B Souto
Journal:  Int J Environ Res Public Health       Date:  2020-06-28       Impact factor: 3.390

7.  Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions.

Authors:  David Couret; Cynthia Planesse; Jessica Patche; Nicolas Diotel; Brice Nativel; Steeve Bourane; Olivier Meilhac
Journal:  Molecules       Date:  2021-10-21       Impact factor: 4.411

8.  Microarchitecture of titanium cylinders obtained by additive manufacturing does not influence osseointegration in the sheep.

Authors:  Louis Rony; Eric Aguado; Bruno Verlee; Florence Pascaretti-Grizon; Daniel Chappard
Journal:  Regen Biomater       Date:  2021-06-25

9.  Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans.

Authors:  Gianfranco Grompone; Patricia Martorell; Silvia Llopis; Núria González; Salvador Genovés; Ana Paula Mulet; Tamara Fernández-Calero; Inés Tiscornia; Mariela Bollati-Fogolín; Isabelle Chambaud; Benoit Foligné; Agustín Montserrat; Daniel Ramón
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human.

Authors:  Brice Nativel; David Couret; Pierre Giraud; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Wildriss Viranaïcken; Christine Robert Da Silva
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.